Analysis on national list of common low-price medicine and medicine sales in Tianjin
10.3969/j.issn.1674-2982.2014.11.003
- VernacularTitle:常用低价药品清单及其在天津市的使用情况分析
- Author:
Mingyue ZHAO
;
Jing WU
- Publication Type:Journal Article
- Keywords:
Low-price medicine;
Expense ratio;
Exclusive varieties
- From:
Chinese Journal of Health Policy
2014;(11):13-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To get the basic situation of the list of low-price medicines and their sales in Tianjin to pro-vide future policy reference. Methods:The low-price medicine list was analyzed through different principles of classifica-tion including the National Essential medicine List ( NEML) , National Reimbursement medicine List ( NRML) and exclu-sive production. The study analyzed the sales status of the low-price medicines in the Tianjin from 2008 to 2011 using the Tianjin Urban Employee Basic Medical Insurance (UEBMI) database. Results:19 classes of chemical medicines and eight classes of traditional Chinese Medicine are included in the low-price medicine list. All of the medicines in the low-price list come from the NRML, and the replication ratio between the NEML and the low-price medicine list is 54. 1%. There are 41 exclusive productions and 149 exclusive formulation productions. From 2008 to 2011, the average ratio of the chemi-cal low-price medicines and traditional Chinese Medicine sales to total medicines sales are 4. 7% and 11. 0%, respective-ly. Both national essential medicines and exclusive formulation production sales ratios are increasing, however the sales ra-tio of exclusive production decreased from 2008 to 2011. Conclusion:The government should pay greater attention to the supply and production of the list’s exclusive production. The sales ratio of low-price medicines to total medicines sales is much lower in the retail pharmacies and tertiary medical institutions than other medical institutions. Suggestions:The gov-ernment should practice the shortage report system of common low-price medicine as soon as possible, with efforts made to implement the global budgeting policy and encourage sales enthusiasm for low-price medicines in retail pharmacies.
